Back to search

Georgia Institute of Technology

Continuous enzymatic reactive crystallization of beta-lactam antibiotics

Abstract

dc:description.abstract

The enzymatic manufacture of beta-lactam antibiotics can be improved and intensified by integrating the synthesis and separation of the antibiotic within a single vessel. Reaction and crystallization within the same unit operation, or reactive crystallization (RC), improves substrate conversions and productivity by protecting the antibiotic from enzymatic degradation. Additionally, incorporation of this process on a continuous platform allows for improved control, greater capacity for the same process footprint, reduced environmental impact, and improved process performance. The use of biocatalysts instead of traditional metal catalysts allows for the operation in mild aqueous conditions, reducing organic solvent usage and eliminating the need for cryogenic refrigeration units which are highly energy intensive. Additionally, biocatalysts yield improved reaction efficiency and decreased total waste production. Applying process analytical technology (PAT) to continuous processes allows for the on-line monitoring of important process variables, such as product purity, but also allows for the monitoring of process conditions such that conditions are never reached which promote a decline in product purity. A model for the reactive crystallization of amoxicillin and cephalexin was utilized to determine attainable operating conditions, ensuring acceptable productivity and conversion. Two similar continuous RC processes were developed for the manufacture of amoxicillin and cephalexin, and various challenges with the incorporation of these processes were addressed. The process was operated robustly for short and long-term runs and the sensitivity of the process to disturbance variables was evaluated via modelling and experimentally. This process will enable a more cost efficient and sustainable production of amoxicillin and cephalexin, and possibly similar antibiotics, with potential for on-demand production of drug substances, which has been shown to be particularly important when considering recent events involving supply chain breakdowns and shortages involving the Covid-19 pandemic, as well as current and potential foreign conflict.

Degree

thesis:*
Level thesis:degree_level
Doctoral
Department dc:contributor.department
Chemical and Biomolecular Engineering
Grantor dc:publisher
Georgia Institute of Technology
Year dc:date.issued
2023

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Harris, Patrick R.
Advisor dc:contributor.advisor
  • Bommarius, Andreas S.
Committee members dc:contributor.committeemember
  • Grover, Martha A.
  • Rousseau, Ronald W.
  • Styczynski, Mark P.
  • Champion, Julie A.
  • Burcham, Christopher L.

Subjects

dc:subject × 3

Rights

Language dc:language.iso
en_US

Identifiers

dc:identifier.*
Handle dc:identifier.uri
https://hdl.handle.net/1853/75172

Chain of custody

source
Harvested from
Georgia Tech
Base URL
repository.gatech.edu/server/oai/request
Last updated
2026-11-19
Source record
OAI-PMH GetRecord
citation

Harris, Patrick R.. Continuous enzymatic reactive crystallization of beta-lactam antibiotics. Doctoral thesis, Georgia Institute of Technology, 2023. https://hdl.handle.net/1853/75172